E-LIB Suche - Ergebnisse für: Kaushik, Viswanath

1

Tofacitinib in Vogt-Koyanagi-Harada disease:

Dutta Majumder, Parthopratim ; Shah, Amravi ; Kaushik, Viswanath
Indian Journal of Ophthalmology. 68 (2020) 9 - p. 1938 , 2020

Link: https://doi.org/10.4103/..

2

Tofacitinib in recalcitrant scleritis: First case report fr..:

Biswas, Jyotirmay ; Pyare, Richa ; Kaushik, Viswanath.
Indian Journal of Ophthalmology. 68 (2020) 9 - p. 1988 , 2020

Link: https://doi.org/10.4103/..

3

A case of idiopathic necrotizing scleritis with secondary g..:

Dutta Majumder, Parthopratim ; Jayshree ; David, RathiniLilian.
Indian Journal of Ophthalmology. 67 (2019) 8 - p. 1360 , 2019

Link: https://doi.org/10.4103/..

4

A case of human leukocyte antigen B-27-associated ocular hy..:

Majumder, ParthopratimDutta ; Lakra, Ruchika ; Yamuna, G..
Indian Journal of Ophthalmology. 66 (2018) 7 - p. 1006 , 2018

Link: https://doi.org/10.4103/..

5

A PATIENT'S JOURNEY: Polymyositis:

Truepenny, Paul ; Kaushik, Viswanath ; Lempp, Heidi
BMJ: British Medical Journal. 344 (2012) 7851 - p. 44-40 , 2012

Link: https://www.jstor.org/st..

6

Real-Life Tolerability and Effectiveness of Adalimumab Bios..:

Kapoor, Sanjiv ; Kaushik, Viswanath V. ; Jain, Rahul..
Rheumatology and Therapy. 6 (2019) 3 - p. 451-459 , 2019

Link: https://doi.org/10.1007/..

7

Real‐life Tolerability and Effectiveness of Adalimumab Bios..:

Kapoor, Sanjiv ; Kaushik, Viswanath V. ; Jain, Rahul..
ACR Open Rheumatology. 1 (2019) 8 - p. 480-484 , 2019

Link: https://doi.org/10.1002/..

8

e21 Real-life efficacy and tolerability profile of a simila..:

Kaushik, Viswanath V
Rheumatology. 57 (2018) suppl_3 - p. , 2018

Link: https://doi.org/10.1093/..

9

How common is methotrexate pneumonitis? A large prospective..:

Sathi, Navtej ; Chikura, Batsirai ; Kaushik, Viswanath V...
Clinical Rheumatology. 31 (2011) 1 - p. 79-83 , 2011

Link: https://doi.org/10.1007/..

10

Why the power of technology rarely goes to the people: a ne..:

Acemoglu, Daron ; Johnson, Simon ; Viswanath, Kaushik - [First edition] . , 2023

Link: https://learning.oreilly..

11

What an FTC noncompete ban could mean for workers and busin..:

Starr, Evan ; Viswanath, Kaushik - [First edition] . , 2023

Link: https://learning.oreilly..

12

Tofacitinib in Vogt-Koyanagi-Harada disease:

Dutta Majumder, Parthopratim ; Shah, Amravi ; Kaushik, Viswanath
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690541/. , 2020

Link: http://www.ncbi.nlm.nih...

13

Tofacitinib in recalcitrant scleritis: First case report fr..:

Pyare, Richa ; Kaushik, Viswanath ; Dutta Majumder, Parthopratim.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690527/. , 2020

Link: http://www.ncbi.nlm.nih...

14

A case of idiopathic necrotizing scleritis with secondary g..:

Dutta Majumder, Parthopratim ; Jayshree ; David, Rathini Lilian.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677064/. , 2019

Link: http://www.ncbi.nlm.nih...

15

Real-Life Tolerability and Effectiveness of Adalimumab Bios..:

Kapoor, Sanjiv ; Kaushik, Viswanath V ; Jain, Rahul..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702582/. , 2019

Link: http://www.ncbi.nlm.nih...